HomeHealth SolutionsEARLY-LIFE PROBIOTIC SOLUTIONS

EARLY-LIFE PROBIOTIC SOLUTIONS

Babies_750x350

Probiotics for the Best of Starts

In early-life, probiotics can help nurture a healthy gut microbiome and promote its smooth and timely evolution. By doing so, they can help ensure a healthy gut function and integrity as well as a proper immune development. We have a large portfolio of scientifically substantiated solutions that are safe and efficient to support infants’ and young children’s gut health and natural defenses. We can design formulas with other ingredients of interest for infants, such as vitamin D or prebiotics, including human milk oligosaccharides (HMOs), fructooligosaccharides (FOS) and inulin.

Our dedicated solutions include Probiokid®, Lacidofil®, B. lactis Lafti® B94, Prenatis™ which total over 30 clinical studies performed in infants and young children with benefits on gut health and natural defenses. Additional strains of interest specifically recommended by pediatricians are also available : ask us about L. rhamnosus GG, S. boulardii and L. reuteri Rosell®-444! Our team has developped adapted dosage forms for early-life, such as drops but also soluble powders with carefully selected natural and delicious flavors.

Latest news

New partnership for early-life synbiotic solutions

Lallemand Health Solutions and dsm-firmenich are joining forces to launch early-life synbiotic solutions, leveraging the synergy of probiotics and human milk oligosaccharides (HMOs).

New Published Results of a New Trial on the Effect of Probiotics on Health in Pregnancy and Infants

The Rosell® Institute for Microbiome and Probiotics by Lallemand in collaboration with Clinique ovo, has published a new study titled “The Effect of Probiotics on Health in Pregnancy and Infants: A Randomized, Double-Blind, Placebo-Controlled Trial[1]“ in the peer-reviewed journal Nutrients, marking a significant advancement in probiotic research in women’s health.

Blog articles

Supporting the Foundations of Health from Day One

The first 1,000 days of life—from conception to around age two—are a decisive window for establishing the foundations of lifelong health. During this period, the body undergoes rapid physiological development, including the maturation of the immune system, digestive tract, and metabolic and cognitive functions. At the heart of this transformation is the gut microbiome—a dynamic ecosystem of microorganisms that plays a pivotal role in shaping early-life development.1

Read more

More news

Lallemand Health Solutions and dsm-firmenich are joining forces to launch early-life synbiotic solutions, leveraging the synergy of probiotics and human milk oligosaccharides (HMOs). Read more

The Brazilian Health Authorities, ANVISA[1]  approved Probiokid® for use in infants and children (from 3-to-36-month-old), reinforcing Lallemand Health Solutions privileged position in the country.

“We are beyond proud! Our product, supported by decades of scientific, marketing and regulatory accomplishments, has achieved the almost impossible nowadays: getting an approval in Brazil! It is the first one this year,” begins Solange Henoud, Vice-President Regulatory and Compliance at Lallemand Health Solutions. “It’s been a while since anyone from the industry has made it this far, but with a documented product such as Probiokid®, with its extensive marketing journey and various regulatory acknowledgements across the globe for infants and children, we felt confident. We hope this approval paves the way for further probiotic approvals to unfold, for the greater benefit of the Brazilian population.” Tells Mrs. Henoud. Read more

For the first time a health authority recognizes that probiotics, particularly Lallemand Health Solutions strains Bifidobacteria infantis Rosell®-33, and Bifidobacteria bifidum Rosell®-71, can help formula-fed babies develop a similar microflora as to breast-fed infants. Read more
Lallemand Health Solutions’ Probiokid®, the world’s best-selling pediatric probiotic formulation, makes the scientific news with its most recent review: “Efficacy of a multi-strain probiotic formulation in pediatric populations: A comprehensive review of clinical studies[1]” published on June 1st, in Nutrients. Read more
Lallemand Health Solutions’ three probiotic strains L. helveticus Rosell®-52 (R0052), B. infantis Rosell®-33 (R0033) and B. bifidum Rosell®-71 (R0071), have now completed the approval process by the National Health Commission of the People’s Republic of China for use in infant food. Read more
One of Lallemand Health Solution’s documented strains, Bifidobacterium lactis Lafti® B94 has recently received a No Questions Letter (NQL) regarding the Generally Recognized as Safe (GRAS) notification from the United States Food and Drug Administration (FDA), meaning it is recognized to be safe to be used in infants, as an ingredient in powdered milk-based infant formula. Read more
Winter is coming! If only there were ways to support children natural defenses to help them go through this season in the best possible condition! But before getting into the ways to keep them strong, the way they might think of their favorite superhero, let’s recap what the immune system is and how it works. Read more
Baby is born. From that moment on, every action could have a lifelong consequence. The birth delivery mode, diet, direct and indirect environments all have impacts. A baby’s body is like a sponge, absorbing what the world has to offer. And this includes billions of microorganisms that will colonize it. From day one, baby’s immune response is activated to test what is accepted, and what is not. Early life external factors shape baby’s microbiota, impacting its immune system. Consequently, a baby’s diet has a great influence on its immune response during the first months of life. [Harper, 2021] Read more

Download our white paper

Download